Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2139406 | Leukemia Research | 2007 | 5 Pages |
Abstract
The suppressor of cytokine signalling-1 (SOCS-1) is a negative regulator of signal transduction mediated by cytoplasmic tyrosine kinases such as the Janus kinases (JAKs). We investigated SOCS-1 expression in bone marrow cells from Philadelphia chromosome negative chronic myeloproliferative disorders (Phâ CMPD) and normal haematopoiesis (n = 121), and additionally in peripheral blood samples (n = 18). Except for chronic idiopathic myelofibrosis harbouring wild-type JAK2, other Phâ CMPD expressed significantly higher SOCS-1 levels of up to 14-fold compared to the control group (p < 0.001) independent of the JAK2 status. The mononuclear cell fraction but not granulocytes in patients with Polycythaemia vera also significantly overexpressed SOCS-1. We conclude that up-regulation of the SOCS-1 gene might reflect a compensatory feedback mechanism with different emphasis among Phâ CMPD subtypes independent of an underlying JAK2 (V617F) mutation.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Oliver Bock, Kais Hussein, Kai Brakensiek, Thomas Buhr, Jerome Schlué, Birgitt Wiese, Hans Kreipe,